Other Guidelines | Page 5 | European Cystic Fibrosis Society (ECFS)

Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis

Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study.

Non-Invasive Ventilation and Clinical Outcomes in Cystic Fibrosis: findings from the UK CF Registry

SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum.

Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells.

Validation of the French 3-year prognostic score using the Canadian Cystic Fibrosis registry.

Comparison of Lung Clearance Index Determined by Washout of N2 and SF6 in Infants and Preschool Children with Cystic Fibrosis

Controlled attenuation parameter: a measure of hepatic steatosis in patients with Cystic Fibrosis

Dental and periodontal manifestations in patients with cystic fibrosis - A systematic review

Eluforsen: a potential new treatment option for people with cystic fibrosis (CF) due to the F508del gene mutation?

first
previous
1
2
3
4
5
6
7
8
9
…
next
last